| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/2002 | CN1368551A Process for creating medicine screening system with ABC1 gene cell target to screen 3G medicine of cardiovascular disease |
| 09/11/2002 | CN1368511A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368510A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368509A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368508A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368504A DNA sequence of dendrobium and method for discriminating its veriety and judging if it is true or false |
| 09/11/2002 | CN1368384A Genetically engineered vaccine of MUC-1 antigen for human breast cancer |
| 09/11/2002 | CN1090679C Monitoring multiple amplification reactions simultaneously and analyzing it |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/10/2002 | US6448476 Plants and plant cells transformation to express an AMPA-N-acetyltransferase |
| 09/10/2002 | US6448475 Transgenic plants can be made that have altered tocopherol levels in their tissues for increased vitamin e supplementation |
| 09/10/2002 | US6448474 Transforming a coffee plant with a vector comprising a nucleic acid sequence from a coffee fruit that codes for an rna that is sense/antisense to a coffee fruit-expressed mrna for acc oxidase; applying ethylene to fruit to ripen |
| 09/10/2002 | US6448473 Construction and use of nucleic acid segments and vectors containing multiple sequences encoding members of a biosynthetic pathway for the synthesis of polylactone biopolymers |
| 09/10/2002 | US6448472 Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the conference of hormone and herbicide resistance |
| 09/10/2002 | US6448471 Nematode-feeding structure specific gene and its application to produce nematode resistant plants |
| 09/10/2002 | US6448470 Mouse has cartilage comprising human col2a1 collagen gene but not mouse col2a1, and a normal skeletal structure |
| 09/10/2002 | US6448469 Production of membrane proteins in the milk of transgenic nonhuman mammals |
| 09/10/2002 | US6448468 Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof |
| 09/10/2002 | US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis |
| 09/10/2002 | US6448391 Ubiquitin-lytic peptide fusion gene constructs with enhanced stability and gene expression |
| 09/10/2002 | US6448390 Mutant protein allows for decreased shedding of the surface protein by suppressing precursor cleavage, while maintaining mutant envelope protein incorporation into a virion |
| 09/10/2002 | US6448389 Human cytomegalovirus DNA constructs and uses therefor |
| 09/10/2002 | US6448388 Polynucleotides encoding proteins sharing sequence similarity with mammalian proteases; proteases are associated with inter alia, regulating development, diabetes, obesity, infertility, modulating cellular processes, and infectious disease |
| 09/10/2002 | US6448386 High molecular weight major outer membrane protein of moraxella |
| 09/10/2002 | US6448382 Loading a mixture of isoforms onto a tsk sulfopropyl cation exchange chromatography column, washing with linear gradient buffer, discarding fraction comprising double clipped isoform and collecting intact and single-clipped isoforms |
| 09/10/2002 | US6448381 DNA encoding heparin-binding growth factor |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448375 Active and inactive CC-chemokine receptor |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448226 Bacillus thuringiensis strains and their insecticidal proteins |
| 09/10/2002 | US6448224 Antibiotics and methods of using the same |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448087 Method for determining and modifying protein/peptide solubility |
| 09/10/2002 | US6448083 Contacting a mammalian cell with filamentous phage particles presenting a ligand on their surfaces, wherein a vector within the phage encodes a gene product under control of a promoter |
| 09/10/2002 | US6448082 An isolated nucleic acid sequence capable of being transferred by conjugation, from a bacterium of the species lactococcus |
| 09/10/2002 | US6448081 Oligonucleotides specifically hybridizable with nucleic acids encoding interleukin 12 p40 subunit |
| 09/10/2002 | US6448080 Antisense modulation of WRN expression |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448074 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 09/10/2002 | US6448073 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 09/10/2002 | US6448071 Effective competitors to t cell receptors and mhc molecules normally involved in transplant rejection and autoimmune disease |
| 09/10/2002 | US6448070 Recombinant plant viruses, especially their use as immunizing agents which carry antigenic sequences from mammalian or other animal pathogens and their use as a system for increased production of polypeptides of interest |
| 09/10/2002 | US6448059 Methods and composition for inhibition of tRNA activities |
| 09/10/2002 | US6448056 Microbial xyloglucan endotransglycosylase (XET) |
| 09/10/2002 | US6448052 To convert ethyl 4-chloroacetoacetate using nadph as a coenzyme to produce ethyl (s)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal ph and temperature; enzyme from candida |
| 09/10/2002 | US6448049 Starch conversion process |
| 09/10/2002 | US6448048 Method for effecting site-directed mutagenesis |
| 09/10/2002 | US6448047 Sample processing to release nucleic acids for direct detection |
| 09/10/2002 | US6448046 Possessing enhanced stability within a host, enabling the sustained systemic transcription of a nucleotide sequence; accomplished by the use of a dual subgenomic promoter system which reduces the frequency of recombination |
| 09/10/2002 | US6448043 Enterococcus faecalis EF040 and uses therefor |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448040 Nucleic acid molecules encoding hypusine mutants having the biological activity, of inhibiting cellular proliferation |
| 09/10/2002 | US6448039 Enhancer sequences for late T cell expressed genes |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448034 Production of variant nisin |
| 09/10/2002 | US6448033 Incubating a sample of ribosomes obtained from a cell-free extract with plasmid dna containing a coding sequence for a protein of interest with an aminoacyl trna having fluorescent label |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
| 09/10/2002 | US6448019 Inhibit vascular smooth muscle cell activation and/or proliferation or enhance vascular endothelial cell activation and/or proliferation or activate estrogen responsive genes in vascular cells. vasoprotective agents are vasospecific, |
| 09/10/2002 | US6448017 In vitro amplification of nucleic acid molecules via circular replicons |
| 09/10/2002 | US6448014 PCR-hybridization assays specific for integrated retroviruses |
| 09/10/2002 | US6448013 Quantitatively determining the amount of polynucleotides in a sample. the distinct polynucleotide targets and standard polynucleotide targets are contacted with detectable probes and independently detectable single or double stranded |
| 09/10/2002 | US6448012 Method for mapping a nucleic acid |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448009 Method for target site selection and discovery |
| 09/10/2002 | US6448007 Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448004 Electrochemiluminescence helicase assay |
| 09/10/2002 | US6448002 Method to detect clinically relevant mutations of the DNA sequence of ki-ras oncogene, its use and a testkit for early diagnosis of tumors |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447995 The viral vector particle content of a medium. a medium is provided and contacted with an excitation energy such that, if a viral vector particle is in the medium, an electron associated with the intrinsically fluorogenic portion of the |
| 09/10/2002 | US6447994 A nucleic acid having a first nucleotide sequence encoding an infectious hepatitis c virus, a second nucleotide sequence encoding a ribozyme, and an inducible promoter operably linked to the first and second nucleotide sequences, |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/10/2002 | US6447804 Dry solid medium for storage and analysis of genetic material |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447770 Biocontrol agents for take-all |
| 09/10/2002 | US6447769 Modified tumor cells to inhibit transforming growth factor |
| 09/10/2002 | US6447768 Methods of gene therapy with a DNA sequence encoding NOS |
| 09/10/2002 | US6447766 Deamidated chemokines |
| 09/10/2002 | US6447764 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles |
| 09/10/2002 | US6447723 Microarray spotting instruments incorporating sensors and methods of using sensors for improving performance of microarray spotting instruments |
| 09/10/2002 | CA2234876C Positive selection vector for bacillus sp. |
| 09/10/2002 | CA2128247C Vaccines based on streptokinase |
| 09/10/2002 | CA2073441C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 09/09/2002 | CA2375276A1 Methods to isolate gene coding and flanking dna |
| 09/08/2002 | CA2380716A1 Dna vaccine using liposome-encapsulated plasmid dna encoding for hemagglutinin protein of influenza virus |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/08/2002 | CA2363461A1 Methods for producing proteins by using cell-free protein synthesis systems |
| 09/06/2002 | WO2002069369A2 Cpg-like nucleic acids and methods of use thereof |
| 09/06/2002 | WO2002069232A2 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | WO2002068955A1 Transgenic knockouts of bace-1 |
| 09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |